Journal Logo

Articles by E. Vichinsky

CLINICAL OUTCOMES OF LENTIGLOBIN GENE THERAPY FOR TRANSFUSION-DEPENDENT β-THALASSAEMIA (TDT) FOLLOWING COMPLETION OF THE NORTHSTAR (HGB-204) STUDY: S141

Walters, M. C.; Kwiatkowski, J. L.; Rasko, J. E.J.; More

HemaSphere. 3:22, June 2019.

RESULTS FROM THE RANDOMIZED PLACEBO-CONTROLLED PHASE 3 HOPE TRIAL OF VOXELOTOR IN ADULTS AND ADOLESCENTS WITH SICKLE CELL DISEASE: S147

Vichinsky, E.; Hoppe, C. C.; Ataga, K. I.; More

HemaSphere. 3:25-26, June 2019.